Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-11
6:04 pm
Unchanged
13GAcutus Medical, Inc.
AFIB
Advent Life Sciences LLP1,619,371
5.8%
0
(Unchanged)
View
2022-02-11
5:59 pm
Purchase
13GAura Biosciences, Inc.
AURA
Advent Life Sciences LLP2,023,857
6.9%
2,023,857increase
(New Position)
View
2021-04-13
2:05 pm
Purchase
13DEloxx Pharmaceuticals, Inc.
ELOX
Advent Life Sciences LLP2,532,270
6.3%
2,532,270increase
(New Position)
View
2021-02-10
3:46 pm
Purchase
13GAcutus Medical, Inc.
AFIB
Advent Life Sciences LLP1,619,371
5.8%
1,619,371increase
(New Position)
View
2021-02-10
3:40 pm
Purchase
13DIterum Therapeutics plc
ITRM
Advent Life Sciences LLP2,890,085
3.5%
2,010,683increase
(+228.64%)
View
2020-02-11
1:57 pm
Sale
13GAxonics, Inc.
AXNX
Advent Life Sciences LLP1,273,859
3.7%
-422,990decrease
(-24.93%)
View
2020-01-29
4:39 pm
Purchase
13DIterum Therapeutics plc
ITRM
Advent Life Sciences LLP879,402
5.9%
11,241increase
(+1.29%)
View
2019-02-11
3:50 pm
Purchase
13GAxonics, Inc.
AXNX
Advent Life Sciences LLP1,696,849
6.1%
1,696,849increase
(New Position)
View
2018-06-08
5:40 pm
Purchase
13DIterum Therapeutics plc
ITRM
Advent Life Sciences LLP868,161
6.2%
868,161increase
(New Position)
View